News

U.S. FDA Approves NEXTSTELLIS®, New Oral Contraceptive
16 Apr 2021
Mayne Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved NEXTSTELLIS.
Learn more

New data on NEXTSTELLIS® presented at ISSWSH conference
8 Mar 2021
New data showing treatment with NEXTSTELLIS™, a novel, investigational combined oral contraceptive
Learn more

Mayne Pharma 2021 Half Year Results Media Release
24 Feb 2021
Mayne Pharma 2021 Half Year Results Media Release
Learn more

Microgestin® 24 Fe tablets launch in the United States
7 Jan 2021
Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the commercial launch of MICROGESTIN® 24 FE
Learn more
40 results - Page 5 of 5